BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 34149291)

  • 1. Hematopoietic Stem Cell Therapy for Wiskott-Aldrich Syndrome: Improved Outcome and Quality of Life.
    Mallhi KK; Petrovic A; Ochs HD
    J Blood Med; 2021; 12():435-447. PubMed ID: 34149291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
    Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
    Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-cell reconstitution after lentiviral vector-mediated gene therapy in patients with Wiskott-Aldrich syndrome.
    Castiello MC; Scaramuzza S; Pala F; Ferrua F; Uva P; Brigida I; Sereni L; van der Burg M; Ottaviano G; Albert MH; Grazia Roncarolo M; Naldini L; Aiuti A; Villa A; Bosticardo M
    J Allergy Clin Immunol; 2015 Sep; 136(3):692-702.e2. PubMed ID: 25792466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic Stem Cell Transplantation for X-Linked Thrombocytopenia With Mutations in the WAS gene.
    Oshima K; Imai K; Albert MH; Bittner TC; Strauss G; Filipovich AH; Morio T; Kapoor N; Dalal J; Schultz KR; Casper JT; Notarangelo LD; Ochs HD; Nonoyama S
    J Clin Immunol; 2015 Jan; 35(1):15-21. PubMed ID: 25388447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wiskott-Aldrich syndrome: diagnosis, clinical and laboratory manifestations, and treatment.
    Ochs HD; Filipovich AH; Veys P; Cowan MJ; Kapoor N
    Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):84-90. PubMed ID: 19147084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wiskott-Aldrich syndrome.
    Notarangelo LD; Miao CH; Ochs HD
    Curr Opin Hematol; 2008 Jan; 15(1):30-6. PubMed ID: 18043243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wiskott-Aldrich syndrome/X-linked thrombocytopenia in China: Clinical characteristic and genotype-phenotype correlation.
    Liu DW; Zhang ZY; Zhao Q; Jiang LP; Liu W; Tu WW; Song WX; Zhao XD
    Pediatr Blood Cancer; 2015 Sep; 62(9):1601-8. PubMed ID: 25931402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome.
    Labrosse R; Chu JI; Armant MA; Everett JK; Pellin D; Kareddy N; Frelinger AL; Henderson LA; O'Connell AE; Biswas A; Coenen-van der Spek J; Miggelbrink A; Fiorini C; Adhikari H; Berry CC; Cantu VA; Fong J; Jaroslavsky J; Karadeniz DF; Li QZ; Reddy S; Roche AM; Zhu C; Whangbo JS; Dansereau C; Mackinnon B; Morris E; Koo SM; London WB; Baris S; Ozen A; Karakoc-Aydiner E; Despotovic JM; Forbes Satter LR; Saitoh A; Aizawa Y; King A; Nguyen MAT; Vu VDU; Snapper SB; Galy A; Notarangelo LD; Bushman FD; Williams DA; Pai SY
    Blood; 2023 Oct; 142(15):1281-1296. PubMed ID: 37478401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome.
    Aiuti A; Biasco L; Scaramuzza S; Ferrua F; Cicalese MP; Baricordi C; Dionisio F; Calabria A; Giannelli S; Castiello MC; Bosticardo M; Evangelio C; Assanelli A; Casiraghi M; Di Nunzio S; Callegaro L; Benati C; Rizzardi P; Pellin D; Di Serio C; Schmidt M; Von Kalle C; Gardner J; Mehta N; Neduva V; Dow DJ; Galy A; Miniero R; Finocchi A; Metin A; Banerjee PP; Orange JS; Galimberti S; Valsecchi MG; Biffi A; Montini E; Villa A; Ciceri F; Roncarolo MG; Naldini L
    Science; 2013 Aug; 341(6148):1233151. PubMed ID: 23845947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into the biology of Wiskott-Aldrich syndrome (WAS).
    Thrasher AJ
    Hematology Am Soc Hematol Educ Program; 2009; ():132-8. PubMed ID: 20008191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome.
    Hacein-Bey Abina S; Gaspar HB; Blondeau J; Caccavelli L; Charrier S; Buckland K; Picard C; Six E; Himoudi N; Gilmour K; McNicol AM; Hara H; Xu-Bayford J; Rivat C; Touzot F; Mavilio F; Lim A; Treluyer JM; Héritier S; Lefrère F; Magalon J; Pengue-Koyi I; Honnet G; Blanche S; Sherman EA; Male F; Berry C; Malani N; Bushman FD; Fischer A; Thrasher AJ; Galy A; Cavazzana M
    JAMA; 2015 Apr; 313(15):1550-63. PubMed ID: 25898053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lentiviral gene therapy corrects platelet phenotype and function in patients with Wiskott-Aldrich syndrome.
    Sereni L; Castiello MC; Di Silvestre D; Della Valle P; Brombin C; Ferrua F; Cicalese MP; Pozzi L; Migliavacca M; Bernardo ME; Pignata C; Farah R; Notarangelo LD; Marcus N; Cattaneo L; Spinelli M; Giannelli S; Bosticardo M; van Rossem K; D'Angelo A; Aiuti A; Mauri P; Villa A
    J Allergy Clin Immunol; 2019 Sep; 144(3):825-838. PubMed ID: 30926529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical features and genotype analysis of 132 patients with Wiskott-Aldrich syndrome].
    Li W; Liu D; Zhang X; Ding Y; Zhao X
    Zhonghua Er Ke Za Zhi; 2015 Dec; 53(12):925-30. PubMed ID: 26887548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Wiskott-Aldrich syndrome.
    Ochs HD
    Semin Hematol; 1998 Oct; 35(4):332-45. PubMed ID: 9801262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful Reduced Intensity Allogeneic Transplant With Full Donor Chimerism and Good Quality of Life in Adolescent Patient With Wiskott-Aldrich Syndrome.
    Ali S; Gacsadi A; McDougall E; Armstrong C; Krueger J; Schechter T; Ali M
    J Pediatr Hematol Oncol; 2017 Jul; 39(5):e267-e269. PubMed ID: 28538502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of human Wiskott-Aldrich syndrome protein in patients' cells leads to partial correction of a phenotypic abnormality of cell surface glycoproteins.
    Huang MM; Tsuboi S; Wong A; Yu XJ; Oh-Eda M; Derry JM; Francke U; Fukuda M; Weinberg KI; Kohn DB
    Gene Ther; 2000 Feb; 7(4):314-20. PubMed ID: 10694812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wiskott-Aldrich syndrome.
    Nonoyama S; Ochs HD
    Curr Allergy Asthma Rep; 2001 Sep; 1(5):430-7. PubMed ID: 11892069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Wiskott-Aldrich Syndrome: An updated review].
    Blancas-Galicia L; Escamilla-Quiroz C; Yamazaki-Nakashimada MA
    Rev Alerg Mex; 2011; 58(4):213-8. PubMed ID: 24007832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and function of the Wiskott-Aldrich syndrome protein.
    Ochs HD; Notarangelo LD
    Curr Opin Hematol; 2005 Jul; 12(4):284-91. PubMed ID: 15928485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
    Muñoz A; Olivé T; Martinez A; Bureo E; Maldonado MS; Diaz de Heredia C; Sastre A; Gonzalez-Vicent M;
    Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.